PKA (protein kinase A) in the fission yeast Schizosaccharomyces pombe controls transcription of genes involved in metabolism, cell growth and sexual development. In the present review, we discuss phenotypes associated with either high or low PKA activity in the context of how they can be used to carry out genetic or small-molecule screens that affect components of the PKA pathway. Although our recent research has focused on the study of heterologously expressed cyclic nucleotide PDEs (phosphodiesterases), these same methods can be used to target other S. pombe proteins or their functionally equivalent orthologues that act in the PKA pathway.
Introduction
PKA (protein kinase A, also known as cAMP-dependent protein kinase), is a serine/threonine kinase involved in many eukaryotic processes, including environmental stress response, metabolic regulation, aging, steroidogenesis, and cell growth and differentiation [1] [2] [3] . In its inactive state, PKA is a tetramer composed of two regulatory subunits and two catalytic subunits. As intracellular cAMP levels rise, the regulatory subunits bind cAMP and undergo a conformational change to release the activated catalytic subunits [3] . cAMP levels reflect the relative rates of synthesis by adenylyate cyclases and hydrolysis by cyclic nucleotide PDEs (phosphodiesterases), both of which are regulated [4] [5] [6] . Additional co-localization of complexes of adenylyate cyclases, PDEs, PKAs and Epacs (exchange proteins activated by cAMP) produce microdomains of cAMP signalling within a cell [7] , so that PKA and Epac activation can be restricted to specific subcellular locations.
In the fission yeast Schizosaccharomyces pombe and the budding yeast Saccharomyces cerevisiae, a G-proteinmediated glucose-sensing mechanism promotes a transient cAMP signal due to adenylate cyclase activation [8] . Feedback regulation of this signal occurs due to PDE activation [9, 10] . The proteins in the S. pombe glucose/PKA pathway that are required for PKA activation include the Git3 GPCR (G-protein-coupled receptor), the Gpa2 Gα subunit, the Git5 Gβ subunit, the Git11 Gγ subunit, the Git2/Cyr1 adenylate cyclase, the Git1 cyclase-binding protein, Hsp90
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(heat-shock protein 90), the Git7 Hsp90 co-chaperone and the Pka1/Git6 catalytic subunit of PKA [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] . Negative regulators of PKA activity include the Cgs2/Pde1 PDE and the Cgs1 regulatory subunit of PKA [10, [22] [23] [24] . Given the conservation of function of many of these proteins between yeast and mammals, as well as the ability to rewire GPCRs to interact with targeted G-proteins [25] , this pathway can be studied as a model for mammalian PKA signalling or can be used to incorporate components of the mammalian pathway into yeast to allow for either genetic or small-molecule screens to directly study these mammalian proteins. In the present paper, we review phenotypes associated with PKA activity and describe how they can be used to perform screens for mutant alleles, cloned genes or compounds that alter PKA activity.
Use of the PKA-repressed fbp1-ura4 reporter
To study the mechanism by which S. pombe cells regulate transcription of the fbp1 (fructose 1,6-bisphosphatase) gene in response to glucose repression, an fbp1-ura4 fusion was constructed that produced reciprocal growth behaviours that reflect the state of glucose signalling [26] (Table 1) . Wild-type cells that repress expression of this reporter in glucose-rich medium are unable to grow in medium lacking uracil, but are resistant to the pyrimidine analogue 5FOA (5-fluoro-orotic acid). This allowed the isolation of mutants that form colonies in glucose-rich media lacking uracil, identifying eight git (glucose insensitive transcription) genes [26] , all of which are required for the activation of PKA. A ninth gene, git11 (Gγ subunit), was identified by a two-hybrid screen for proteins that bind the Git5 Gβ subunit of the G protein [15] . The fbp1-ura4 reporter also facilitated the cloning of these git genes as well as of multicopy suppressors by their ability to restore 5FOA R (5FOA-resistant) growth due to increased PKA activity (Table 1 ). In addition, the negative regulators of PKA, Cgs1 and Cgs2, originally identified as suppressors of a lethal meiosis conferred by the loss of Ran1/Pat1 activity [22] , were also identified in genetic screens for mutations that suppress the partial or complete loss of adenylate cyclase activity by their ability to confer 5FOA R growth to a 5FOA S (5FOA-sensitive) cyr1/git2 mutant strain [10, 24] . Just as a mutation in the cgs2 PDE gene restores 5FOA R growth to a strain expressing a hypomorphic form of adenylate cyclase [10] , so does chemical inhibition of PDE activity confer 5FOA R growth on a strain whose cAMP levels are insufficient to activate PKA. Our laboratory has generated a collection of strains expressing 15 of the 21 mammalian PDE genes and shown that either exogenous cAMP or cGMP can be used to activate PKA. We have determined conditions under which inhibition of these PDEs, representing ten of the 11 PDE families, can be detected by 5FOA R growth [27, 28] (Figure 1A ). We have successfully carried out HTSs (high-throughput screens) for small-molecule inhibitors of heterologously expressed PDE4, PDE7, PDE8 and PDE11 enzymes, identifying compounds that display biological activity when tested in mammalian cell culture [29] [30] [31] [32] . PDE inhibitors that are able to diffuse in solid media can also be used to prevent colony formation on medium lacking uracil ( Figure 1B) , allowing for genetic screens of a target PDE gene for mutant alleles that produce a compound-resistant form of the enzyme to restore colony formation in the presence of the PDE inhibitor. Although our focus has been on PDEs, one could use a 5FOA R growth screen to identify small-molecule activators of PKA in cells that heterologously express PKA together with its cognate regulatory subunit in cells lacking cAMP. Thus genetic and chemical screens using strains carrying the fbp1-ura4 reporter can be used to identify both increases and decreases in PKA activity.
PKA repression of sexual development
The cAMP/PKA pathway negatively regulates sexual development, as exogenous cAMP or mutations in the cgs1 or cgs2 genes, resulting in elevated PKA activity, inhibit mating and sporulation [22] [23] [24] 33] . Conversely, mutations in genes required for glucose-mediated activation of PKA in order to repress fbp1 transcription also allow cells to mate and form asci in the absence of nutrient starvation [11, [14] [15] [16] 18, 19] (Table 1 ). An iodine-staining assay can be utilized to identify the mating phenotype in which colonies of homothallic (h 90 ) cells containing asci produced by mating and sporulation are darkly stained [34] . As such, homothallic strains lacking either the Cgs2 PDE or the Cgs1 regulatory subunit of PKA do not stain with iodine vapours due to their high PKA activity. This allowed for the cloning of cgs1 and cgs2 from genomic libraries by the fact that their expression in mutant host strains reduced PKA activity to restore iodine staining [22] , and for the detection of transformants that express active alleles of mammalian PDE genes in a host cell that lacks PDE activity ( Figure 1C) . Conversely, the elevation of PKA activity to inhibit mating can be detected in a screen by the loss of iodine staining or by the restoration of growth of a pat1 ts (ran1 ts ) strain at the non-permissive temperature, preventing it from undergoing a lethal meiosis as a haploid [22] .
PKA repression of entry into stationary phase
S. pombe cells must reduce their PKA activity to enter stationary phase either in colonies or in liquid cultures grown to saturation. In fact, the cgs1 PKA regulatory subunit gene and the cgs2 PDE gene were so named because strains carrying mutations in these genes continue to grow in stationary phase, and rapidly lose viability after reaching saturation [22] . This phenotype can be exploited in screens for cells with reduced PKA activity due to their survival advantage over cells with elevated PKA activity in a saturated culture (Table 1) . On the basis of our interest in PDEs, we have used this phenotype to enrich for two types of mutations in PDE genes from pools of transformants expressing PCR-generated alleles of a given PDE gene. In each case, we are looking for mutant PDEs that are more active than the wild-type enzyme under the specific conditions, leading to lower PKA activity and successful entry into stationary phase. For example, smallmolecule inhibition of a heterologously expressed PDE will activate PKA to inhibit stationary phase entry. Thus cells that express an inhibitor-resistant form of the enzyme will retain PDE activity to lower PKA activity. Alternatively, cells that express a cAMP-specific PDE, such as PDE7A [4, 6] , show a defect in stationary phase entry when grown in medium containing cGMP ( Figure 1D ). We have used this to enrich for and identify transformants that express a mutant form of PDE7A that is able to hydrolyse cGMP in order to enter stationary phase in medium containing cGMP ( Figure 1E ). Thus the stationary phase entry phenotype can be used to enrich for cells with reduced PKA activity from a heterogeneous population of cells. 
Use of a PKA-repressed fbp1-GFP reporter
Although the fbp1-ura4 reporter could theoretically be used to screen cells in liquid culture for reduced PKA activity on the basis of growth in the absence of uracil, we have found that this phenotype is too leaky for robust screens. Therefore we recently constructed an fbp1-GFP reporter that can be used to detect low PKA activity in cells growing in liquid culture by fluorescence (Table 1 and Figure 1F ), (A. Magee and C.S. Hoffman, unpublished work). Similar to the fbp1-ura4 reporter, this should be useful in smallmolecule HTSs; however, in this case one would be screening for compounds that lower PKA activity, which would lead to an increase in fluorescence. Such screens could be carried out to identify PDE activators that would further reduce cAMP or cGMP levels. Alternatively, one could screen for inhibitors of PKA, adenylate cyclase or adenylate cyclase activators such as Gα S [5, 35] . Screens involving heterologous expression of adenylate cyclases together with their activators could be 'tuned' to fall into a sensitive response range through the selection of an appropriate PDE gene to include in this signalling module. A high level of cAMP synthesis may need to be paired with a potent PDE from the PDE4 or PDE7 family, whereas moderate or low levels of cAMP synthesis may require either the absence of a PDE or the inclusion of one that displays significantly less activity when expressed in S. pombe [28] . The fbp1-GFP reporter should also be useful in screening transformants either by screening colonies directly or by sorting for highly fluorescent cells using FACS in order to screen plasmid libraries for genes whose expression reduces PKA activity. In this way, the fbp1-GFP reporter should be useful in screens for mutations, small molecules or clones of genes that reduce PKA activity to elevate fbp1 transcription.
Conclusion
PKA signalling and PDE function are very important in mammals, with a wide range of diseases associated with either elevated or reduced PKA activity [36, 37] . In the present paper, we have described how the fission yeast S. pombe can be used for genetic or chemical screens to identify changes in PKA activity. These screens take advantage of two PKA-repressed reporters that we have constructed; an fbp1-ura4 reporter that is best suited for detecting elevated PKA activity and an fbp1-GFP reporter that is best suited for detecting reduced PKA activity. In addition, PKA-repressed sexual development can be used to detect either increases or decreases in PKA activity, although not in an HTS format, whereas stationary phase entry can be used to enrich for cells possessing reduced PKA. Given the ease of genetic engineering in S. pombe and the fact that PKA signalling does not involve large multi-subunit complexes, it should be possible to use S. pombe as a host for screens focused on various components of a cAMP signalling pathway to identify mutations, small molecules or genes of interest as we have done with PDEs.
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